Incorporating flexibility into protein-ligand docking

One of the major goals of current drug discovery methods is the correct treatment of the flexibility of the receptor (i.e., protein) in small ligand docking. Computer-aided drug discovery through ligand docking-based virtual screening is already a key component in the lengthy and costly process of developing new drugs not only for academy but also for the pharmaceutical industries.

Short name and number: 
IFLPD (221208)
Name of US Partner: 
THE SCRIPPS RESEARCH INSTITUTE
Contact: 

FUNDACIO PRIVADA INSTITUT DE RECERCA BIOMEDICA IRB (ES) / COARASA Carles

Participating Countries: 
United States
Area: 

Health

Category: 

FP7 Project with U.S. partner